• Pharma Mar’s board will stay at 11 members after María Victoria Mateos Manteca did not take up her independent director seat.
• Her appointment, made at the June 30, 2026 shareholder meeting, lapsed because she did not obtain the required authorizations to accept.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharma Mar SA published the original content used to generate this news brief on July 21, 2026, and is solely responsible for the information contained therein.